EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Correction to “A Machine Learning‐Optimized Immunogenic Cell Death Signature Reveals Tumor Immunogenicity and the Immunotherapy Response of Pancancer”

MedComm – Future Medicine · 2026-12 · 5 (4)

DOI: 10.1002/mef2.70092 ↗

Kurz gefasst

Fachartikel in der Zeitschrift MedComm – Future Medicine, online erschienen am 03.11.2026. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Correction to “A Machine Learning‐Optimized Immunogenic Cell Death Signature Reveals Tumor Immunogenicity and the Immunotherapy Response of Pancancer”. MedComm – Future Medicine, 5(4). https://doi.org/10.1002/mef2.70092

Vancouver

Correction to “A Machine Learning‐Optimized Immunogenic Cell Death Signature Reveals Tumor Immunogenicity and the Immunotherapy Response of Pancancer”. MedComm – Future Medicine. 2026;5(4). doi:10.1002/mef2.70092

BibTeX
@article{euvimed2026,
  title = {Correction to “A Machine Learning‐Optimized Immunogenic Cell Death Signature Reveals Tumor Immunogenicity and the Immunotherapy Response of Pancancer”},
  journal = {MedComm – Future Medicine},
  year = {2026},
  volume = {5},
  number = {4},
  doi = {10.1002/mef2.70092}
}
Kostenlos starten →